Novel Technology Commercialization

Blazing a trail isn’t easy, but that’s not why you’re doing it. Navigating strategy for novel technologies and creating new, uncharted markets requires creativity, innovation, and experience. We’re here to help.

Our Experts

Stephane Budel

Miguel Edwards

Andrew Aijian

Carl Schoellhammer

Schedule a Call

Related Client Results

All Client Results

NIPT Menu and Technology Offerings

A leading diagnostics player asked DeciBio to characterize the evolving NIPT market to help inform strategic positioning regarding menu offerings and technological approach

View

Voice-of-Customer Research

Research Tools

RWD Biobank Offering Go-to-Market Strategy

The ventures arm of a top-20 U.S. health system sought support developing a go-to-market strategy for RWD-augmented biobank offerings

View

Voice-of-Customer Research

Go-to-Market Strategy

Pricing Strategy

Competitive Analysis

Financial Services

Investment Diligence into Leading Oncology Diagnostic Provider

A global private equity firm wanted to project the revenues and competitive positioning of a leading oncology diagnostics provider to support a growth capital investment

View

Voice-of-Customer Research

Competitive Analysis

Revenue Projection

Due Diligence

Clinical Diagnostics

Longitudinal Monitoring of Cancer Early Detection Market

A top-10 diagnostics player wanted to monitor market development activities and competitive intelligence in the early cancer detection space

View

Competitive Analysis

Research Tools

Methylation Analysis Opportunity Identification for Ultra-Sensitive Detection Platform

A leader in research tools and clinical diagnostic development asked us to evaluate the opportunity for an ultrasensitive detection platform in methylation analysis

View

Target Identification

Pharma & Biotech

Early-Stage Cancer Biomarker Testing and Treatment Landscape Assessment

A top-10 biopharma wanted to assess how the biomarker testing and treatment landscape would change, and the potential impact on the use of their drug, in response to a recent approval of a new competing cancer therapy approved in earlier lines of treatment

View

Competitive Analysis

Voice-of-Customer Research

Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch